Alexis Wood, CCC-SLP in Dpo, AE - Speech-Language Pathologist

Alexis Wood, CCC-SLP is a Speech-language Pathologist based in Dpo, Armed Forces Europe. Alexis Wood is licensed to practice in Virginia (license number 2202007714) and her current practice location is Unit 7130 Box 1118, Dpo, Armed Forces Europe. She can be reached at her office (for appointments etc.) via phone at (703) 955-4805.

NPI number for Alexis Wood is 1811433972 and her current mailing address is Unit 7130 Box 1118, Dpo, Armed Forces Europe. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1811433972.

Contact Information

	Alexis Wood, CCC-SLP
	Unit 7130 Box 1118, Dpo, AE 09709-1118
	(703) 955-4805
	Not Available

Healthcare Provider's Profile

Full Name	Alexis Wood
Gender	Female
Speciality	Speech-language Pathologist
Location	Unit 7130 Box 1118, Dpo, Armed Forces Europe
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1811433972
Provider Enumeration Date: 01/13/2017
Last Update Date: 01/13/2017

Medical Identifiers

Medical identifiers for Alexis Wood such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1811433972	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
235Z00000X	Speech-language Pathologist	2202007714 (Virginia)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Alexis Wood is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Alexis Wood, CCC-SLP Unit 7130 Box 1118, Dpo, AE 09709-1118 Ph: () -	Alexis Wood, CCC-SLP Unit 7130 Box 1118, Dpo, AE 09709-1118 Ph: (703) 955-4805

News Archive

Experimental drug shows promise as viable treatment for anemia of inflammation

An experimental drug designed to help regulate the blood's iron supply shows promise as a viable first treatment for anemia of inflammation, according to results from the first human study of the treatment published online today in Blood, the Journal of the American Society of Hematology.

Sonic Innovations to unveil new 12-channel BTE hearing aid at AudiologyNOW! conference

Sonic Innovations, Inc. will unveil its new 12-channel super power behind-the-ear (BTE) hearing aid, Endura, at the AudiologyNOW! conference in San Diego, California, April 14 through 17. Endura provides exceptional amplification for those suffering from severe-to-profound hearing loss.

Why do women typically experience poorer dental health than men?

Reproduction pressures and rising fertility explain why women suffered a more rapid decline in dental health than did men as humans transitioned from hunter-and-gatherers to farmers and more sedentary pursuits, says a University of Oregon anthropologist.

Dartmouth researchers use new strategies to target drug-resistant pathogens

By engineering antibacterial enzymes, Dartmouth investigators led by Karl Griswold, PhD are using novel strategies to target the prevalent drug-resistant bacterium Staphylococcus aureus.

Alexis Wood, CCC-SLP - Speech-Language Pathologist in Dpo, AE